Products from unlicensed manufacturer contain carcinogenic substances 

UAE, October xx, 2015 - The UAE Ministry of Health has issued a warning for consumers to abstain from buying or using the herbal products ‘Miracle Diet 30’ and ‘Miracle Rock 48’ manufactured by ‘One Minute Miracle Inc.,’ as nutritional supplements because they contain hazardous and carcinogenic substances.

H.E. Dr. Amin Al Amiri, Assistant Undersecretary for the Ministry of Health’s Health Policy & License Department, said that the US Food and Drug Administration (FDA) and the manufacturer have issued a warning to not use ‘Miracle Rock 48’ as a dietary supplement and sexual tonic for men. The supplement contains an unlicensed pharmaceutical substance, Thiosildenafil, which might cause a sharp drop in blood pressure to a dangerously low level, posing a significant risk to patients with heart disease, diabetes, or high proportion dhow and those who are taking drugs containing nitrates. The ‘Miracle Diet 30’ is used as a dietary supplement for weight loss and contains unlicensed Phenolphthalein which is considered a carcinogen and is not used in the pharmaceutical industry.

The Assistant Undersecretary emphasized that the Ministry of Health has taken all necessary measures to withdraw both products from the markets as well as prohibit their sale and import, noting that the manufacturer is not registered with the Ministry’s Drug Administration. He called on the public to cooperate with the Ministry to eliminate any harmful practices that may be detrimental to an individual’s or community’s health and not be misled by illegal promotional methods.

H.E. Dr. Al Amiri underlined the Ministry’s regulations and policies to check any kind of herbal medicine prior to circulation to ensure conformity with international standards and prevent any danger to consumers. He said that the UAE Ministry of Health is in regular contact with international organizations and institutions related to the health and medication, including the European Medicines Agency, the Medicines and Healthcare Products Regulatory Agency (UK), Therapeutic Goods Administration (Australia), as well as the USA’s FDA.